572 related articles for article (PubMed ID: 29055062)
1. Cognition, quality-of-life, and symptom clusters in breast cancer: Using Bayesian networks to elucidate complex relationships.
Xu S; Thompson W; Ancoli-Israel S; Liu L; Palmer B; Natarajan L
Psychooncology; 2018 Mar; 27(3):802-809. PubMed ID: 29055062
[TBL] [Abstract][Full Text] [Related]
2. Cognitive performance of breast cancer survivors in daily life: Role of fatigue and depressed mood.
Small BJ; Jim HSL; Eisel SL; Jacobsen PB; Scott SB
Psychooncology; 2019 Nov; 28(11):2174-2180. PubMed ID: 31418499
[TBL] [Abstract][Full Text] [Related]
3. Sleep problems in breast cancer survivors 1-10 years posttreatment.
Lowery-Allison AE; Passik SD; Cribbet MR; Reinsel RA; O'Sullivan B; Norton L; Kirsh KL; Kavey NB
Palliat Support Care; 2018 Jun; 16(3):325-334. PubMed ID: 28508735
[TBL] [Abstract][Full Text] [Related]
4. Cancer treatment effects on cognition and depression: The moderating role of physical activity.
Bedillion MF; Ansell EB; Thomas GA
Breast; 2019 Apr; 44():73-80. PubMed ID: 30685529
[TBL] [Abstract][Full Text] [Related]
5. Pretreatment Psychoneurological Symptoms and Their Association With Longitudinal Cognitive Function and Quality of Life in Older Breast Cancer Survivors.
Tometich DB; Small BJ; Carroll JE; Zhai W; Luta G; Zhou X; Kobayashi LC; Ahles T; Saykin AJ; Clapp JD; Jim HSL; Jacobsen PB; Hurria A; Graham D; McDonald BC; Denduluri N; Extermann M; Isaacs C; Dilawari A; Root J; Rini C; Mandelblatt JS;
J Pain Symptom Manage; 2019 Mar; 57(3):596-606. PubMed ID: 30472317
[TBL] [Abstract][Full Text] [Related]
6. Pre-treatment symptom cluster in breast cancer patients is associated with worse sleep, fatigue and depression during chemotherapy.
Liu L; Fiorentino L; Natarajan L; Parker BA; Mills PJ; Sadler GR; Dimsdale JE; Rissling M; He F; Ancoli-Israel S
Psychooncology; 2009 Feb; 18(2):187-94. PubMed ID: 18677716
[TBL] [Abstract][Full Text] [Related]
7. Subjective cognition and memory lapses in the daily lives of breast cancer survivors: Examining associations with objective cognitive performance, fatigue, and depressed mood.
Veal BM; Scott SB; Jim HSL; Small BJ
Psychooncology; 2023 Aug; 32(8):1298-1305. PubMed ID: 37381150
[TBL] [Abstract][Full Text] [Related]
8. Testing a novel account of the dissociation between self-reported memory problems and memory performance in chemotherapy-treated breast cancer survivors.
Paquet L; Verma S; Collins B; Chinneck A; Bedard M; Song X
Psychooncology; 2018 Jan; 27(1):171-177. PubMed ID: 28129471
[TBL] [Abstract][Full Text] [Related]
9. Quality of life, problems, and needs of disease-free breast cancer survivors 5 years after diagnosis.
Schmidt ME; Wiskemann J; Steindorf K
Qual Life Res; 2018 Aug; 27(8):2077-2086. PubMed ID: 29740782
[TBL] [Abstract][Full Text] [Related]
10. Sleep, fatigue, depression, and circadian activity rhythms in women with breast cancer before and after treatment: a 1-year longitudinal study.
Ancoli-Israel S; Liu L; Rissling M; Natarajan L; Neikrug AB; Palmer BW; Mills PJ; Parker BA; Sadler GR; Maglione J
Support Care Cancer; 2014 Sep; 22(9):2535-45. PubMed ID: 24733634
[TBL] [Abstract][Full Text] [Related]
11. Relationship of fatigue with cognitive performance in women with early-stage breast cancer over 2 years.
Gullett JM; Cohen RA; Yang GS; Menzies VS; Fieo RA; Kelly DL; Starkweather AR; Jackson-Cook CK; Lyon DE
Psychooncology; 2019 May; 28(5):997-1003. PubMed ID: 30761683
[TBL] [Abstract][Full Text] [Related]
12. Comparison of fatigue and fatigability correlates in Korean breast cancer survivors and differences in associations with anxiety, depression, sleep disturbance, and endocrine symptoms: a randomized controlled trial.
Jang MK; Han J; Kim SH; Ko YH; Kim SY; Kim S
BMC Cancer; 2021 Jul; 21(1):855. PubMed ID: 34311713
[TBL] [Abstract][Full Text] [Related]
13. Reductions in sleep quality and circadian activity rhythmicity predict longitudinal changes in objective and subjective cognitive functioning in women treated for breast cancer.
Ancoli-Israel S; Liu L; Natarajan L; Rissling M; Neikrug AB; Youngstedt SD; Mills PJ; Sadler GR; Dimsdale JE; Parker BA; Palmer BW
Support Care Cancer; 2022 Apr; 30(4):3187-3200. PubMed ID: 34957532
[TBL] [Abstract][Full Text] [Related]
14. Sleep disturbance and symptom burden in sarcoidosis.
Benn BS; Lehman Z; Kidd SA; Miaskowski C; Sunwoo BY; Ho M; Sun S; Ramstein J; Gelfand JM; Koth LL
Respir Med; 2018 Nov; 144S():S35-S40. PubMed ID: 29628134
[TBL] [Abstract][Full Text] [Related]
15. NeuroCog FX study: A multicenter cohort study on cognitive dysfunction in patients with early breast cancer.
Rick O; Reuß-Borst M; Dauelsberg T; Hass HG; König V; Caspari R; Götz-Keil G; Pfitzner J; Kerschgens C; Fliessbach K; Hoppe C
Psychooncology; 2018 Aug; 27(8):2016-2022. PubMed ID: 29771474
[TBL] [Abstract][Full Text] [Related]
16. Objective-subjective disparity in cancer-related cognitive impairment: does the use of change measures help reconcile the difference?
O'Farrell E; Smith A; Collins B
Psychooncology; 2017 Oct; 26(10):1667-1674. PubMed ID: 27278814
[TBL] [Abstract][Full Text] [Related]
17. Self-reported chemotherapy-related cognitive impairment compared with cognitive complaints following menopause.
Vega JN; Dumas J; Newhouse PA
Psychooncology; 2018 Sep; 27(9):2198-2205. PubMed ID: 29904964
[TBL] [Abstract][Full Text] [Related]
18. Symptoms, clusters and quality of life prior to surgery for breast cancer.
Denieffe S; Cowman S; Gooney M
J Clin Nurs; 2014 Sep; 23(17-18):2491-502. PubMed ID: 24329603
[TBL] [Abstract][Full Text] [Related]
19. A Pilot Study of a Cognitive-Behavioral Intervention for Breast Cancer Survivors.
Becker H; Henneghan AM; Volker DL; Mikan SQ
Oncol Nurs Forum; 2017 Mar; 44(2):255-264. PubMed ID: 28222075
[TBL] [Abstract][Full Text] [Related]
20. Factors associated with cognitive impairment during the first year of treatment for nonmetastatic breast cancer.
Rodriguez N; Fawcett JM; Rash JA; Lester R; Powell E; MacMillan CD; Garland SN
Cancer Med; 2021 Feb; 10(4):1191-1200. PubMed ID: 33455070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
